We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVGW
376
DELISTED
Calavo Growers
CVGW
| $23.6M | 0.08% |
244,434
-272
| -0.1% | -$25.4K |
|
377
JB Hunt Transport Services
JBHT
$26.2B
| $23.6M | 0.08% |
258,508
-18,205
| -7% | -$1.72M |
|
378
LivaNova
LIVN
$4.49B
| $23.4M | 0.08% |
325,741
-129,241
| -28% | -$9.46M |
|
|
NVTA
379
DELISTED
Invitae Corporation
NVTA
| $23.4M | 0.08% |
997,191
-329,646
| -25% | -$7.02M |
|
|
ACIA
380
DELISTED
Acacia Communications Inc
ACIA
| $23M | 0.07% |
488,337
-56,289
| -10% | -$2.96M |
|
381
Aon
AON
$81.2B
| $22.9M | 0.07% |
+118,700
| New | +$21.5M |
|
382
American Express
AXP
$227B
| $22.9M | 0.07% |
185,264
+56,234
| +44% | +$6.6M |
|
383
Kornit Digital
KRNT
$708M
| $22.8M | 0.07% |
720,358
+159,638
| +28% | +$4.41M |
|
384
Arcosa
ACA
$7.13B
| $22.6M | 0.07% |
601,059
-98,991
| -14% | -$3.39M |
|
385
Insulet
PODD
$11.8B
| $22.6M | 0.07% |
189,013
+7,791
| +4% | +$799K |
|
386
Gilead Sciences
GILD
$165B
| $22.1M | 0.07% |
327,455
-44,033
| -12% | -$2.9M |
|
|
WP
387
DELISTED
Worldpay, Inc.
WP
| $22.1M | 0.07% |
180,214
+51,864
| +40% | +$6.15M |
|
388
Teladoc Health
TDOC
$1.64B
| $22.1M | 0.07% |
332,412
+112,728
| +51% | +$6.57M |
|
389
Global Payments
GPN
$23.5B
| $21.7M | 0.07% |
135,716
-4,212
| -3% | -$626K |
|
390
Humana
HUM
$46.1B
| $21.4M | 0.07% |
+80,642
| New | +$20.5M |
|
391
Semtech
SMTC
$10.4B
| $21.3M | 0.07% |
443,614
-63,576
| -13% | -$3.09M |
|
|
SCS
392
DELISTED
Steelcase
SCS
| $20.9M | 0.07% |
1,222,634
+701,802
| +135% | +$11.7M |
|
393
Willdan Group
WLDN
$1.08B
| $20.9M | 0.07% |
559,888
+170,303
| +44% | +$6.16M |
|
394
Zimmer Biomet
ZBH
$18.5B
| $20.8M | 0.07% |
182,104
-117,523
| -39% | -$13.8M |
|
395
CSX Corp
CSX
$95.6B
| $20.6M | 0.07% |
797,700
-3,600
| -0.4% | -$92.8K |
|
396
OSI Systems
OSIS
$3.62B
| $20.5M | 0.07% |
181,875
-3,484
| -2% | -$351K |
|
397
Eaton
ETN
$150B
| $20.4M | 0.07% |
244,800
-256,500
| -51% | -$20.8M |
|
398
O'Reilly Automotive
ORLY
$76.4B
| $20.3M | 0.07% |
825,030
+138,285
| +20% | +$3.5M |
|
399
Elanco Animal Health
ELAN
$12.9B
| $20.3M | 0.07% |
600,598
+457,472
| +320% | +$14.9M |
|
400
Leidos
LDOS
$14.9B
| $20.1M | 0.07% |
251,500
-13,000
| -5% | -$949K |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.